跳至主要内容
临床试验/NCT06320899
NCT06320899招募中不适用

Mid- or High-flex Rods Versus Low-flex Rods of SpineShape System IV for Treatment of Degenerative Lumbar Spine Diseases - a Prospective, Multicenter, Randomized Controlled Non-inferiority Study

SpineSave AG4 个研究点 分布在 1 个国家目标入组 126 人开始时间: 2024年6月4日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
126
试验地点
4
主要终点
Visual Analogue Scale (VAS) lower back pain

研究概览

简要总结

The purpose of this multi-center, randomized, clinical study is to show that the treatment of degenerative lumbar spine with high- or mid-flex rods is not inferior to the treatment with low-flex rods in terms of clinical and safety-related results.

The primary aim is to compare the reduction in back pain after the treatment with high- or mid-flex rods with that after treatment with low-flex rods. Secondary, the functionality after treatment with high- or mid-flex rods will be compared to that after treatment with low-flex rods.

详细描述

Dynamic stabilization systems for the lumbar spine are no novelty. The SpineShape System IV builds on the experience of previous systems and attempts to provide additional benefits primarily through three different and relatively elastic rod stiffnesses. 126 subjects with degenerative symptoms in 1 to 2 segments of the lumbar spine L1 to S1 will be recruited. The participants will be randomized in a 1:1:1 ratio to undergo implantation of either the elastic (experimental product group 1), medium (experimental product group 2) or stiff rod (comparison product group).

The aim of the study is to show that the treatment of degenerative lumbar spine with elastic or medium rod variants is not inferior to treatment with hard rods in terms of clinical and safety-related results. This is checked by completing a questionnaire before the surgical procedure and 3 months, 12 months, 24 months and 60 months after the surgical procedure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • degenerative symptoms in 1 to 2 segments in the lumbar spine L1-S1
  • signed informed consent of participant
  • confirmation of the participant that the attendance of follow-up visits are intended
  • Body-Mass-Index < 32
  • Pedicle screw axis distance < 30mm
  • one or more of the following indications:
  • (dynamic) stenosis in the spinal canal
  • neuroforaminal stenosis
  • facet joint syndrome / spondylarthrosis
  • discopathy (recurrent disc hernia)
  • degenerative spondylolisthesis (Meyerding <1)
  • instability (hypermobility with antelishtesis, hypomobility with retrolisthesis if decompressed)

排除标准

  • missing bone structure, e.g. due to congenital anomalies or sever anatomical deformities that make anchoring of the implant impossible
  • damaged structural tissue, e.g. due to a bone fracture
  • application to the thoracic or cervical spine
  • pronounced idiopathic scoliosis
  • spondylolisthesis > Meyerding grad 1
  • isthmic spondolylysis
  • bone tumor
  • osteochondrosis modic type I, II or III
  • osteoporosis, which could impair screw anchoring
  • history with third party implants
  • patients with an active local or systemic infection
  • known allergy to titatnium alloys
  • skeleton in growth (epiphyseal joints not closed)
  • severe muscular neuronal or vascular disease
  • immunosuppresive therapy
  • long-term therapy with cortisone
  • heavy smokers (regular consumption of more than six cigarettes per day), drug addicts and alcoholics
  • chronic pain patients
  • incapable of judgment or emergency situation
  • implantation during pregnancy

结局指标

主要结局

Visual Analogue Scale (VAS) lower back pain

时间窗: 24 months post-implantation

self reported back pain intensity using Visual Analogue Scale system. 0 "no pain" to 10 "worst possible pain"

次要结局

  • segmental mobility index level(3, 12, 24, 60 months post-implantation)
  • medication consumption(3, 12, 24, 60 months post-implantation)
  • Visual Analogue Scale (VAS) leg pain(3, 12, 24, 60 months post-implantation)
  • walking duration(3, 12, 24, 60 months post-implantation)
  • adverse events(after 3, 12, 24, 60 months post-implantation)
  • ability to work/ activity (for retirees)(3, 12, 24, 60 months post-implantation)

研究者

发起方
SpineSave AG
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验